|
Form Serial Number: |
DA20240826E00010
|
1.
Date of relevant event: |
23/08/2024 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
3.
Stock code: |
02137 |
4.
Name of listed corporation: |
Brii Biosciences Ltd. - B |
5.
Class of shares: |
Ordinary Shares |
6.
Number of issued shares in class: |
730,242,410 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
Li |
(Other names) |
Ankang |
|
|
|
10.
Name of director (Chinese): |
李安康 |
11.
Chinese Character Code as printed on HKID Card: |
|
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
1316 | There has been a change in nature of your interest in the shares because: any other event (you must briefly describe the relevant event in the Supplementary Information box) | |
|
|
36,125 |
|
|
|
|
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 8,012,833 | 1.10 |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 8,012,833 | 1.10 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
| |
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 31/08/2021 | 18/09/2030 | USD | 0 | USD | 0.130 | | | 1,866,668 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 13/07/2022 | 18/09/2030 | USD | 0 | USD | 0.130 | | | 1,200,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 17/09/2022 | 17/09/2031 | HKD | 1 | HKD | 47.600 | | | 116,500 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 17/09/2021 | 17/09/2024 | HKD | 1 | HKD | 47.600 | | | 864,333 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 17/09/2022 | | HKD | 0 | | | | | 40,500 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 20/01/2022 | | HKD | 0 | | | | | 162,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 21/09/2023 | 21/09/2032 | HKD | 1 | HKD | 6.454 | | | 1,065,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 21/09/2023 | | HKD | 0 | | | | | 856,125 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 23/08/2024 | 23/08/2033 | HKD | 1 | HKD | 3.010 | | | 545,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 23/08/2024 | | HKD | 0 | | | | | 108,375 |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| | | | | |
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
| | |
Total number of shares in which a director is interested under sections 317 and 318 | |
|
|
34.
Supplementary information: |
In Box 24, upon vesting of the RSUs granted by the Company on August 23, 2023 under the Post-IPO Share Award Scheme of the Company, Ankang Li received 36,125 shares.
|
35.
Log/Serial Number of the previous form: |
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
Date of filing this Form 3A: |
26/08/2024 (dd/mm/yyyy)
|
|